Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Envoy Medical (COCH) Long-Term Debt Issuances (2022 - 2025)

Envoy Medical's Long-Term Debt Issuances history spans 4 years, with the latest figure at $5.0 million for Q2 2025.

  • For Q2 2025, Long-Term Debt Issuances rose 100.0% year-over-year to $5.0 million; the TTM value through Sep 2025 reached $15.0 million, changed 0.0%, while the annual FY2024 figure was $20.0 million, 100.0% up from the prior year.
  • Long-Term Debt Issuances for Q2 2025 was $5.0 million at Envoy Medical, roughly flat from $5.0 million in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $7.5 million in Q3 2024 and bottomed at $2.0 million in Q4 2022.
  • The 4-year median for Long-Term Debt Issuances is $4.5 million (2023), against an average of $4.2 million.
  • The largest YoY upside for Long-Term Debt Issuances was 150.0% in 2024 against a maximum downside of 16.67% in 2024.
  • A 4-year view of Long-Term Debt Issuances shows it stood at $2.0 million in 2022, then soared by 50.0% to $3.0 million in 2023, then surged by 66.67% to $5.0 million in 2024, then changed by 0.0% to $5.0 million in 2025.
  • Per Business Quant, the three most recent readings for COCH's Long-Term Debt Issuances are $5.0 million (Q2 2025), $5.0 million (Q1 2025), and $5.0 million (Q4 2024).